| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2021 | Sep 28, 2021 | Traws Pharma, Inc. | Director | Buy | 91.3 | +5,952 | 38.69% | ✗ | $25K |
| Feb 16, 2021 | Feb 17, 2021 | Traws Pharma, Inc. | Director | Buy | 91.3 | +25,000 | 12.15% | ✗ | $25K |
| Nov 24, 2020 | Nov 27, 2020 | Traws Pharma, Inc. | Director | Buy | 91.3 | +38,774 | 23.23% | ✗ | $10K |
| Jun 9, 2020 | Jun 10, 2020 | Celldex Therapeutics, Inc. | Director | Buy | 91.3 | +8,305 | 188.79% | ✗ | $24.9K |
| Nov 25, 2019 | Nov 26, 2019 | Traws Pharma, Inc. | Director | Buy | 91.3 | +150,000 | 885.37% | ✗ | $30K |
| Sep 25, 2019 | Sep 26, 2019 | Traws Pharma, Inc. | Director | Buy | 91.3 | +7,260 | 74.98% | ✗ | $11.6K |
| Aug 24, 2018 | Aug 28, 2018 | Celldex Therapeutics, Inc. | Director | Buy | 91.3 | +40,000 | 153.86% | ✗ | $19.2K |
| Apr 26, 2017 | Apr 28, 2017 | Traws Pharma, Inc. | Director | Buy | 91.3 | +11,906 | 48.77% | ✗ | $25K |